These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 10221489)

  • 1. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of DR match of blood donor and recipient on the formation of T- and B-cell antibodies and on renal allograft outcome.
    van Hooff JP; van den Berg-Loonen PM
    Transpl Int; 1992; 5 Suppl 1():S599-600. PubMed ID: 14621886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-class II antibody production prolongs renal allograft survival.
    Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
    Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation.
    Hiesse C; Busson M; Buisson C; Farahmand H; Bierling P; Benbunan M; Bedrossian J; Aubert P; Glotz D; Loirat C; Rondeau E; Viron B; Bleux H; Lang P
    Kidney Int; 2001 Jul; 60(1):341-9. PubMed ID: 11422770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
    Lagaaij EL; Hennemann IP; Ruigrok M; de Haan MW; Persijn GG; Termijtelen A; Hendricks GF; Weimar W; Claas FH; van Rood JJ
    N Engl J Med; 1989 Sep; 321(11):701-5. PubMed ID: 2671729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
    Mahoney RJ; Taranto S; Edwards E
    Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
    Jeannet M; Benzonana G; Arni I
    Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
    Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Husberg B; Klintmalm G; Maurer W
    Lancet; 1986 Jul; 2(8498):66-9. PubMed ID: 2873380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplantation blood transfusion revisited.
    van Twuyver E; Mooijaart RJ; ten Berge IJ; van der Horst AR; Wilmink JM; Kast WM; Melief CJ; de Waal LP
    N Engl J Med; 1991 Oct; 325(17):1210-3. PubMed ID: 1922208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation.
    van der Mast BJ; Balk AH
    Transplantation; 1997 May; 63(10):1514-9. PubMed ID: 9175819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function.
    McKenna RM; Lee KR; Gough JC; Jeffery JR; Grimm PC; Rush DN; Nickerson P
    Transplantation; 1998 Jul; 66(1):38-43. PubMed ID: 9679819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.